Is Momenta A Good Fit For JNJ? |
| August 20, 2020 | August 2020 Bond Updates |
|
The stock price of Momenta Pharmaceuticals, a pharmaceutical company best known for its immunology therapies, has rallied around 26% over recent weeks (vs. about a 50% gain in the S&P 500) to $31 as of August 18, after falling to a low of $24 in late March, when a rapid increase in the number... |
| View more at: https://www.forbes.com/sites/greatspeculations/2020/08/20/is-momenta-a-good-fit-for-johnson--johnson/ |
| Related News |
|